
Photo: depositphotos.com
Jun 25, 2025, 07:04
ESMO Presents Findings on ADC Target Expression in Ovarian Cancer at ESMO Gynae25
ESMO – European Society for Medical Oncology posted on LinkedIn:
“ADCs present a promising therapeutic option, however the expression patterns of key ADC targets remain unclear.
This study presented at ESMO Gynae25 evaluated the expression of five ADC targets to assess their potential utility in Ovarian Cancer.
Findings reveal targetable alterations, that could lead to better therapeutic options and improved patient outcomes.”
Read Further: 20 Posts Not to Miss from ESMO Gynaecological Cancers Congress 2025.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 20, 2025, 10:17
Jul 20, 2025, 10:08
Jul 20, 2025, 09:16
Jul 20, 2025, 08:47
Jul 20, 2025, 08:42
Jul 20, 2025, 08:38